Emerging targets for antimalarial drugs

Bibliography

• COWMAN AF: The Molecular basis of resistance to the sulfones, sulfonamides and dihydrofolate Inhibitors. In: Malaria Parasite Biology. Pathogenesis and Protection. IW Sherman (Ed.) ASM Press, Washington DC (1999):317–330.
   Google Scholar
• BZIK DJ, LI WB, HORII T, INSELBURG J: Molecular Cloning and sequence analysis of the PlasmadMm falciparum dihydrofolate reductase - thimidylate synthase gene. Proc. Nati Acad. ScL USA (1987) 84:8360–8364.
   PubMed Web of Science ®Google Scholar
• TRIGLIA T, COWMAN AF: Primary structure and expression of dihydropteroate synthetase gene of Plasmodium falciparum. Proc. Nati Acad. Li. USA (1994) 91:7149–7153.
   PubMed Web of Science ®Google Scholar
• COWMAN AF, MORRY MJ, BIGGS BA et al.: Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc. Natl Acad. Li. USA (1988) 85:9109–9113.
   PubMed Web of Science ®Google Scholar
• WANG P, BROBEY RKB, HORII T et al.: Utilization of exogenous folate in the human malaria parasite P falciparum and its critical role in antifolate drug synergy. Mal Microbial (1999) 32:1254–1262.
   PubMedGoogle Scholar
• •Exogenous folate makes DHPS enzyme a relevant target.
   Google Scholar
• SIRAWARAPORN W, PRAPANWATTANA P, SIRAWARAPORN R et al.: The dihydrofolate reductase domain of PlasmadMm falciparum thymidylate synthase -dihydrofolate reductase. Gene synthesis, expression and anti-folate-resistant mutants. ..1 Biol. Chem. (1993) 268:21637–21644.
   Google Scholar
• SHERMAN LW: Purine and pyrimidine metabolism of asexual stages. In: Malaria - Parasite Biology, Pathogenesis and Protection. IW Sherman (Ed.), ASM press, Washington DC (1998):177–184.
   Google Scholar
• DADDONA PE, WISEMAN WP, LAMBROS C et al.: Human malaria parasite adenosine deaminase: characterization in host enzyme-deficient erythrocyte culture. ..1 Biol. Chem. (1984) 259:1472–1475.
   Google Scholar
• DADDONA PE, WISEMAN WP, MILHOUSE W et al.: Expression of human malaria parasite purine nucleoside phosphorylase in host enzyme-deficient erythrocyte culture: enzyme characterization and identification of novel inhibitors. ..1 Biol. Chem. (1986) 261:11667–11673.
   Google Scholar
• QUEEN SA, VANDER JAGT D, REYES P: Properties and substrate specificity of a purine phosphoribosykransferase from the human malaria parasite, Plasmodium falciparum. Mal. Biochem. Parasite]. (1988) 30:123–134.
   PubMedGoogle Scholar
• MARSHALL VM, COPPEL RL: Characterization of the gene encoding adenylosuccinate lyase of Plasmodium falciparum. Mal. Biochem. Parasite]. (1997) 88:237–241.
   PubMedGoogle Scholar
• KRUNGKRAI J, CERAMI J, HENDERSON GB: Pyrimidine biosynthesis in parasitic Protozoa: purification of a monofunctional dihydroorotase from Plasmodium berghei and Crithidia fasciculate. Biochemistry (1990) 29:6270–6275.
   PubMed Web of Science ®Google Scholar
• HUDSON AT, DICKINS M, GINGER CD et al.: A broad spectrum anti-infective agent with activity against malaria and opportunistic infections in IDS patients. Drugs. Exp. OM. Res. (1991) 17:427–435.
   PubMedGoogle Scholar
• SRIVASTAVA IK, ROTTENBERG H, VAIDYA AB: Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite. ..I Biol. Chem. (1997) 272:3961–3966.
   Google Scholar
• •Provides a second mechanism for atavoquone action.
   Google Scholar
• LOOAREESUWAN S, VIRAVAN C, WEBSTER HK et al.: Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am...1 Trap. Med. Hyg. (1996) 54:62–66.
   Google Scholar
• VAIDYA AB: Mitochondrial physiology as a target for atovaquone and other antimalarials. In: Malaria- Parasite Biology. pathogenesis and Protection. IW Sherman (Ed.) ASM Press, Washington DC (1998):355–368.
   Google Scholar
• ROOTH E, Jr.: Carbohydrate metabolism: Connection between host cell and parasite. Blood Cells (1990) 16:453–460.
   PubMedGoogle Scholar
• SUBBAYYA INS, RAY SS, BALARAM P, BALARAM H: Metabolic enzymes as potential targets in Plasmodium falciparum Indian.j Med. Res. (1997) 106:79–94.
   Google Scholar
• MAKLER MT, HINRICHS DJ: Measurement of the lactate dehydrogenase activity of PlasmadMm falciparum as an assessment of parasitemia. Am. ..1 Trap. Med. Hyg. (1993) 48:205–210.
   PubMed Web of Science ®Google Scholar
• DZIERSZINSKI F, POPESCU O, TOURSEL C et al.: The protozoan parasite T gandli expresses two functional plant-like glycolytic enzymes. Implictions for evolutionary origin of apicocomplexans. Biol. Chem. (1999) 274:24888–24895.
   Google Scholar
• SLOMIANNY C: Three dimensional reconstruction of the feeding process of the malarial parasite. Blood Cells (1990) 16:369–378.
   PubMedGoogle Scholar
• GOLDBERG DE, SLATER AFG, CERAMI A, HENDERSON GB: Hemolgobin degradation in the malaria parasite PlasmadMm falciparum: an ordered process in a unique organelle. Proc. Nati Acad. Sci. USA (1990) 87:2931–2935.
   PubMedGoogle Scholar
• •Explains the role of cysteine and aspartic proteases in haemoglobin degradation.
   Google Scholar
• FRANCIS SE, GLUZMAN IY, OKSMAN A. et al Characterization of native falcipain, an enzyme involved in Plasmodium falciparum degradation. Md. Biochem. Parasitol. (1996) 83:189–200.
   PubMed Web of Science ®Google Scholar
• ROSENTHAL PJ, MESHNICK R: Hemoglobin processing and the metabolism of amino acids, heme and iron. In: Malaria - Parasite Biology, pathogenesis and Protection. IW Sherman (Ed.) ASM Press, Washington DC (1998):355–368.
   Google Scholar
• KAMCHIONWONGPAISAN S, SAMOFF E, MESCHNICK SR: Identification of hemoglobin degradation products in PlasmodMm falciparum. Mol. Biochem. Parasitol.(1997) 86:179–186.
   PubMedGoogle Scholar
• LE BONNIEC S, DEREGNANCOURT C, REDEKER V et al.: Plasmepsin II, an acidic hemoglobinase from the Plasmodium falciparum food vacuole, is active at neutral pH on the host erythrocyte membrane skeleton J. Bid. Chem. (1999) 274:14218–14223.
   Google Scholar
• EGGLESON KK, DUTTIN KL, GOLDBERG DE: Identification and characterization of Falcilysin, a met allopeptidase involved in hemoglobin catabolism within the malarial parasite PlasmodMm falciparum. j Biol. Chem. (1999) 274:32411–32417.
   PubMed Web of Science ®Google Scholar
• ROSENTHAL PJ: WOLLISH WS, PALMER JT, RASNICK D: Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. j Chu. Invest. (1991) 88:1467–1472.
   PubMed Web of Science ®Google Scholar
• LI R, KENYON GL, COHEN FE et al.: In vitro antimalarial activity of chalcones and their derivatives. j Med. Chem. (1995) 38:5031–5037.
   PubMed Web of Science ®Google Scholar
• DOMINQUEZ JN, LOPEZ S, CHARRUS J et al.: Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease. j Med. Chem. (1997) 40:2726–2732.
   PubMedGoogle Scholar
• SILVA AM, LEE AY, GULNIK SV et al.: Structure and inhibition of plasmepsin II, a hemoglobin degrading enzyme from PlasmodMm falciparum. Proc. Nati Acad. Sci. USA (1996) 93:10034–10039.
   PubMed Web of Science ®Google Scholar
• ROSENTHAL PJ: Conservation of key amino acids among the cysteine proteases of multiple malarial species. Mol. Biochem. Parasitol. (1996) 75:255–260.
   PubMedGoogle Scholar
• ORJIH A, BANYAL HS, CHEVLI R, FITCH CD: Hemin lyses malaria parasites. Science (1981) 214:667–669.
   PubMed Web of Science ®Google Scholar
• •First evidence for the mechanism of action of chloroquine.
   Google Scholar
• FITCH CD: Malaria and red cell. Ciba Foundation Symposium (1983) 94:222–232.
   PubMedGoogle Scholar
• SULLIVAN AD, MESHNICK SR: Haemozoin: Identification and quantification. Parasitol. Today (1996) 12:161–163.
   PubMedGoogle Scholar
• PAGOLA S, STEPHENS PW, SCOTT-BOHLE D et al: The structure of malaria pigment P-haematin. Nature (2000) 404:307–310.
   PubMed Web of Science ®Google Scholar
• ••Provides a new perspective on haemozoinformation.
   Google Scholar
• SLATER AFG, CERAMI A: Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature (1992) 355:167–169.
   PubMed Web of Science ®Google Scholar
• EGAN TJ, ROSS DC, ADAMS PA: Quinoline antimalarial drugs inhibit spontaneous formation of P-haematin (malaria pigment) FEBS Lett. (1994) 352:54–57.
   Google Scholar
• DORN A, STOFFEL R, MATILE H et al.: Malarial hemozoin/P-haematin supports haem polymerization in the absence of protein. Nature (1995) 374:269–271.
   PubMed Web of Science ®Google Scholar
• PANDEY AV, TEKWANI BL: Formation of haemozoin/P-haematin under physiological conditions is not spontaneous. FEBS Lett. (1996) 393:189–193.
   PubMed Web of Science ®Google Scholar
• BENDRAT K, BERGER BJ, CERAMI A: Haem polymerization in malaria. Nature (1995) 378:138.
   PubMed Web of Science ®Google Scholar
• SULLIVAN DJ: GLUZMAN IY, GOLDBERG DE: Plasmodium hemozoin formation mediated by histidine-rich proteins. Science (1996) 271:219–222.
   PubMed Web of Science ®Google Scholar
• PADMANABAN G, RANGARAJAN PN: Heme metabolism of Plasmodium is a major antimalarial target. Biochem. Biophys. Res. Comm. (2000) 268:665–668.
   PubMed Web of Science ®Google Scholar
• FITCH CD, CHEVLI R, BANYAL HS et al. Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine - ferriprotoporphyrin IX complex. Antimicrob. Agents. Chemother. (1982) 21:819–822.
   PubMed Web of Science ®Google Scholar
• SULLIVAN DJ, MATILE H, RIDLEY RG, GOLDBERG DE: A common mechanism for blockade of heme polymerization by antimalarial quinolines. j Biol. Chem. (1998) 273:31103–31107.
   PubMed Web of Science ®Google Scholar
• EGAN TJ, MAVUSO WM, NEOKAZI KK: The mechanism of I3-hematin formation in acetate solution. Parallels between hemozoin formation and biomineralization process. Biochemistry (2001) 40:204–213.
   Google Scholar
• PANDEY AV, TEKWANI BL, SINGH RL, CHAUHAN VS: Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification steps in malarial parasite. J. Biol. Chem. (1999) 274:19383–19388.
   PubMed Web of Science ®Google Scholar
• BHISUTTIBHAN J, PAN XQ, HOSSLER PA et al.: The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin. _J. Biol. Chem. (1998) 273:16192–16198.
   PubMedGoogle Scholar
• GINSBURG H, FAMIN O, ZHANG J, KRUGLIAK M: Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem. Pharmacol. (1998) 15:1305–1313.
   Google Scholar
• ATAMNA H, GINSBURG H: The malaria parasite supplies glutathione to its host cell. Investigation of glutathione metabolism in human erythrocyte infected with Plasmodium falciparum. Eur. j Biochem. (1997) 250:670–679.
   Google Scholar
• LORIA P, MILLERS, FOLEY M, TILLEY L: Inhibition of the peroxidative decomposition of haem as the basis of action of chloroquine and other quinoline antimalarials. Biochem. j (1999) 339:363–370.
   PubMed Web of Science ®Google Scholar
• PANDEY AV, BISHT H, BABBARWAL VK et al.: Mechanism of malarial haem detoxification inhibition by chloroquine. Biochem. j (2001) 355:333–338.
   PubMedGoogle Scholar
• SUROLIA N, PADMANABAN G: Chloroquine inhibits heme dependent protein synthesis in PlasmodMm falciparum. Proc. Natl. Acad. Sci. USA (1991) 88:4788–4792.
   Google Scholar
• •Provides evidence for an alternative mode of chloroquine action through haeme.
   Google Scholar
• KARTHIKEYAN G: Role of heme in chloroquine resistance in the malarial parasite. PhD Thesis of the Indian Institute of Science, Bangalore (1997).
   Google Scholar
• SHANZER A, LIBMAN J, LYTTON SD et al.: Reversed siderophores act as antimalarial agents. Proc. Natl. Acad. Sci. USA (1991) 88:6585–6589.
   PubMed Web of Science ®Google Scholar
• LYTTON SD, MESTER B, DAYANL et al.: Mode of action of iron (III) chelators as antimalarials: I: membrane permeation properties and cytotoxic activity. Blood (1993) 81:214–221.
   PubMed Web of Science ®Google Scholar
• MABEZA GF, BIEMBA G, GORDENK VR: Chemical studies of iron chelators in malaria. Acta. HaematoL (1996) 95:78–86.
   PubMed Web of Science ®Google Scholar
• FOOTE SJ, KYLE DE, MARTIN RK, et al.: Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature (1990) 345:255–258.
   Google Scholar
• SANCHEZ CP, WUNSCH S, LANZER M: Identification of a chloroquine importer in Plasmodium falciparum. j Biol. Chem. (1997) 272:2652–2658.
   PubMedGoogle Scholar
• SU X, KIRKMAN LA, FUJIOKA H, WELLEMS JE: Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant I? falciparum in Southeast Asia and Africa. Cell (1997) 91:593–603.
   PubMed Web of Science ®Google Scholar
• •Implicates Cg2 allele in chloroquine resistance.
   Google Scholar
• BRAY PG, JANNEH O, RAYNES KJ et al.Cellular uptake of chloroquine is dependent on binding ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum. J. Cell Biol. (1999) 145:363–376.
   PubMed Web of Science ®Google Scholar
• REED MB, SALIBA KJ, CARUANA SR et al.: Pghl modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature (2000) 403:906–909.
   PubMed Web of Science ®Google Scholar
• FIDOCK DA, NOMURA T, COOPER RA et al.: Allelic modifications of Cg2and Cgj genes do not alter chloroquine response of drug resistant Plasmodium falciparum. Biochem. Parasitol. (2000) 110:1–10.
   PubMed Web of Science ®Google Scholar
• ••Provides evidence that Cg2 allele is notdirectly involved in chloroquine resistance.
   Google Scholar
• FIDOCK DA, NOMURA T, TALLEY AK et al.: Mutations in the Plasmodium falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Ma. Cell (2000) 6:861–871.
   PubMed Web of Science ®Google Scholar
• ••Identifies a new gene PfCRT inchloroquine resistance.
   Google Scholar
• DJIMDE A, PHARM D, DOUMBO OK et al.: A molecular marker for chloroquine-resistant falciparum malaria. New Eng. J. Med. (2001) 344:257–263.
   PubMed Web of Science ®Google Scholar
• ••A field study validating PfCRT associationwith chloroquine reistance.
   Google Scholar
• MARTIN SK, ODOULA AM, MILHOUS WK: Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science (1987) 235:899–901.
   PubMed Web of Science ®Google Scholar
• MARTINEY JA, CERAMI A, SLATER AFG: Verapamil reversal of chloroquine resistance in the malarial parasite PlasmodMm falciparum is specific for resistant parasites and independent of the weak base effect. J. Biol. Chem. (1995) 270:22393–22398.
   PubMedGoogle Scholar
• MILHOUS WK, KYLE DE: Introduction to the modes of action and mechanism of resistance to antimalarials. In Malaria: Parasite Biology, Pathogenesis, and Protection IW Sherman (Ed.), ASM Press, Washington DC (1998):303–316.
   Google Scholar
• DE D, KROGSTAD FM, COGSWELL FB, KROGSTAD DJ: Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro. Am. J. Trap. Med. Hyg. (1996) 55:579–583.
   Google Scholar
• SUROLIA N, PADMANABAN G: De novo biosynthesis of heme offers a new chemotherapeutic target in the human malarial parasite. Biochem. Biophys. Res. Comm. (1992) 187:744–750.
   PubMed Web of Science ®Google Scholar
• •Demonstrates de novo haeme synthesis and as a drug target.
   Google Scholar
• BONDAY ZQ, TAKETANI S, GUPTA PD, PADMANABAN G: Heme biosynthesis by the malarial parasite: Import of 8-aminolevulinate dehydrase from the host red cell. ..J. Biol. Chem. (1997) 272:21839–21846.
   PubMedGoogle Scholar
• •Demonstrates import of a host enzyme into the parasite.
   Google Scholar
• BONDAY ZQ, DHANASEKHARAN S, RANGARAJAN PN, PADMANABAN G: Import of host 8-aminolevulinate dehydrase into the malarial parasite: identification of a new drug target. Nature Med. (2000) 6:898–903.
   PubMed Web of Science ®Google Scholar
• ••Demonstrates protein import from themedium into the parasite.
   Google Scholar
• MCFADDEN GI, ROOS DS: Apicomplexan plastids as drug targets. Trends MicrobioL (1999) 7:328–333.
   PubMed Web of Science ®Google Scholar
• WILSON RJM, DENNY DW, DREISER PR et al.: Complete gene map of the plastid-like DNA of the malarial parasite PlasmodMm falciparum. j Ma. Biol. (1996) 261:155–172.
   Google Scholar
• ••Reviews the role of apicoplast in theparasite.
   Google Scholar
• WILSON CM, SMITH AB, BAYLON RV: Characterization of the 8-aminolevulinate synthase gene homologue in P falciparum. Biochem. ParasitoL(1996) 75:271–276.
   PubMedGoogle Scholar
• SATO S, TEWS, I, WILSON RJM: Impact of a Plastid-bearing endocymbiont on apicomplexan genomes. InternatL ParasitoL (2000) 30:427–439.
   PubMedGoogle Scholar
• ROBERTS F, ROBERTS CW, JOHNSON JJ et al.: Evidence for the shikimate pathway in apicomplexan parasites. Nature (1998) 393:801–805.
   PubMed Web of Science ®Google Scholar
• KEELING PJ, PALMER JD, DONALD RGK et al: Shikimate pathway in apicomplexan parasites. Nature (1999) 397:219.
   PubMedGoogle Scholar
• WALLER RF, KEELING PJ, DONALD RGK et al.: Nuclear-encoded proteins target to the plastid in Toxoplasrna gondii and Plasmodium falciparum. Proc. NatL Acad. Sci. USA (1998) 95:12352–12357.
   PubMed Web of Science ®Google Scholar
• •Demonstrates targeting of enzymes to the apicoplast.
   Google Scholar
• WALLER RF, REED MB, COWMAN AF, MCFADDEN GI: Protein trafficking to the Plastid of Plasmodium falciparum is via the secretory pathway. EMBO J. (2000) 19:1794–1802.
   PubMed Web of Science ®Google Scholar
• SUROLIA N, SUROLIA A: Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nature Med. (2001) 7:167–173.
   PubMed Web of Science ®Google Scholar
• ••Identifies enoyl - ACP reductase as a newdrug target.
   Google Scholar
• JOMAA H, WIESNER J, SANDERBRAND S et al.: Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science (1999) 285:1573–1576.
   PubMed Web of Science ®Google Scholar
• •Demonstrates plant-like enzymes in isoprenoid synthesis as drug targets.
   Google Scholar
• FREVERT U, CRISANTI A: Invasion of vertebrate cells: hepatocytes. In: Malaria Parasite Biology, Pathogenesis and Protection IW Sherman (Ed.), ASM Press, Washington DC (1998):73–91.
   Google Scholar
• BARN WELL JW, GALINSKI R: Invasion of vertebrate cells: erythrocytes. In: Malaria: Parasite Biology, Pathogenesis and Protection IW Sherman (Ed.), ASM Press, Washington DC (1998):93–120.
   Google Scholar
• NAIK RS, DAVIDSON EA, GOWDA D: Developmental stage specific biosynthesis of glycosylphosphatidylinositol anchors in intraerythrocytic Plasmodium falciparum and its inhibition in a novel manner by mannosamine. j Biol. Chem. (2000) 275:24506–24511.
   PubMedGoogle Scholar
• BARUCH DI, PASLOSKE BL, SINGH HB et al.: Cloning the I? falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell (1995) 82:77–87.
   PubMed Web of Science ®Google Scholar
• CHEN Q, BARRAGAN A, FERNANDEZ V et al.: Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malarial parasite, R falciparum. j Esp. Med. (1998) 187:15–23.
   Google Scholar
• BEESON JG, ROGERSON SJ: COOKE BM et al.: Adhesion of Plasmodium fakiparum-infected erythrocytes to hyaluronic acid in placental malaria. Nature Med. (2000) 6:86–90.
   Google Scholar
• VIAL HJ, ANCELIN ML: Malarial lipids, an overview. In: Subcellular Biochemistry JL Avila, JR Harris (Eds.), Plenum Press, New York (1992):259–306.
   Google Scholar
• VIAL HJ, VIDAL-SAILHANT V, ANCELIN ML et al: New drugs against malaria with special reference to effectors of the plasmodial phospholipid metabolism. In: Multith-ug resistance in emerging arid re-emerging diseases. RC Mahajan, A Therwath (Eds.), Narosa Publishing House, New Delhi (1999):175–189.
   Google Scholar
• ELMENDORF HG, HALDAR K: Plasmodium falciparum exports the Golgi marker sphingomyelin synthase into a tubovesicular network in the cytoplasm of mature erythrocytes. j. Cell Biol. (1994) 124:449–462.
   PubMed Web of Science ®Google Scholar
• LAUER SA: RATHOD PK, GHORI, N HALDAR K: A membrane network of nutrient import in red cells infected with the malaria parasite. Science (1997) 276:1122–1125.
   PubMedGoogle Scholar
• ••Demonstrates role of tubovesicularmembrane in nutrient uptake.
   Google Scholar
• GINSBURG H, KIRK H: Membrane transport in malaria-infected erythrocytes. In: Malaria: Parasite Biology, Pathogenesis and Protection. IW Sherman (Ed.) ASM Press, Washington DC (1998):219–232.
   Google Scholar
• BERRIMAN M, FAIRLAMB AH: Detailed characterization of a cyclophilin from the human malarial parasite Plasmodium falciparum. Biochem. J. (1998) 334:437–445.
   PubMedGoogle Scholar
• TIFFERT T, GINBURG H: KRUGLIAK M: et al.: Antimalarial activity of clomitrazole in in vitro cultures of P falciparum. Proc. Natl. Acad. Sci. USA (2000) 97:331–336.
   PubMed Web of Science ®Google Scholar
• MULLER S, DA' DARA A, LURSEN K et al.: In the human malarial parasite P falciparum polyamines are synthesized by a bifunctional ODC S-adomet decarboxylase. j. Biol. Chem. (2000) 275:8097–8102.
   Google Scholar
• SLAYDEN RA, LEE RE, BARRY CE. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis. Molecular Microbial (2000) 38:514–525.
   Google Scholar
• ••Identifies FasII enzymes as targets for INH.
   Google Scholar